Tissue-specific RNA surveillance? Nonsense-mediated mRNA decay causes collagen X haploinsufficiency in Schmid metaphyseal chondrodysplasia cartilage.

Mutations resulting in a premature termination codon (PTC) are a major cause of inherited disorders, and the majority of these mutant RNA transcripts are subjected to nonsense-mediated mRNA decay (NMD). This RNA surveillance results in reduced mutant allele expression, the extent of which can impact on the clinical severity. The molecular mechanisms of NMD in mammalian cells, its relationship to splicing and translation, downstream sequence elements and binding factors remains only partially understood. Currently there is little information on whether the extent of NMD is gene- or tissue-specific, although nonsense mutation inhibition of RNA splicing has been shown to exhibit some tissue and gene specificity in vitro. Schmid metaphyseal chondrodysplasia results from heterozygous mutations in the gene for collagen X (COL10A1), expressed by the hypertrophic chondrocytes of growth plate cartilage. In one patient a PTC mutation has been shown to result in complete NMD and collagen X haploinsufficiency in cartilage. Here we show that, in this patient, and in another with a different collagen X PTC mutation also leading to complete NMD in cartilage, the mutant mRNAs were not subjected to NMD in non-cartilage cells (lymphoblasts and bone cells). These data suggest that novel RNA surveillance mechanisms may exist in cartilage and that tissue specificity of NMD could be of importance in understanding the molecular pathology of nonsense mutations. Furthermore, the demonstration of collagen X haploinsufficiency in the second patient to be studied at the level of tissue expression, confirms that nonsense mutations leading to complete mutant collagen X mRNA degradation in cartilage is an important molecular cause of SMCD.

[1]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[2]  R. Savarirayan,et al.  Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability. , 2000, American journal of medical genetics.

[3]  M. Hentze,et al.  Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway , 2002, Genome Biology.

[4]  M. Kohonen-Corish,et al.  Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense‐mediated mRNA instability , 1999, Human mutation.

[5]  D. Marks,et al.  Metaphyseal Chondrodysplasia Type Schmid Mutations Are Predicted to Occur in Two Distinct Three-dimensional Clusters within Type X Collagen NC1 Domains That Retain the Ability to Trimerize* , 1999, The Journal of Biological Chemistry.

[6]  W. Cole,et al.  Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. , 1993, The Journal of biological chemistry.

[7]  J. A. Chapman,et al.  Macromolecular organization of chicken type X collagen in vitro , 1991, The Journal of cell biology.

[8]  J. Bateman,et al.  Site-directed Mutagenesis of Human Type X Collagen , 1996, The Journal of Biological Chemistry.

[9]  H. Dahl,et al.  Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency. , 1998, Human molecular genetics.

[10]  N. Bulleid,et al.  Folding and Assembly of Type X Collagen Mutants That Cause Metaphyseal Chondrodysplasia-type Schmid , 1999, The Journal of Biological Chemistry.

[11]  D. Chan,et al.  Phenotypic and biochemical consequences of collagen X mutations in mice and humans. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[12]  Jun Wang,et al.  Boundary‐independent polar nonsense‐mediated decay , 2002, EMBO reports.

[13]  D. Sillence,et al.  Multiexon Deletions in the Type I Collagen COL1A2 Gene in Osteogenesis Imperfecta Type , 1996, The Journal of Biological Chemistry.

[14]  Patrick P.L. Tam,et al.  Abnormal Compartmentalization of Cartilage Matrix Components in Mice Lacking Collagen X: Implications for Function , 1997, The Journal of cell biology.

[15]  L. Maquat When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. , 1995, RNA.

[16]  S. Antonarakis,et al.  Nomenclature for the description of human sequence variations , 2001, Human Genetics.

[17]  O. Bogin,et al.  Insight into Schmid metaphyseal chondrodysplasia from the crystal structure of the collagen X NC1 domain trimer. , 2002, Structure.

[18]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[19]  J. Bateman,et al.  Collagen X Chains Harboring Schmid Metaphyseal Chondrodysplasia NC1 Domain Mutations Are Selectively Retained and Degraded in Stably Transfected Cells* , 2002, The Journal of Biological Chemistry.

[20]  T. Schmid,et al.  Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues , 1985, The Journal of cell biology.

[21]  W. Cole,et al.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. , 1984, The Biochemical journal.

[22]  Massimo Caputi,et al.  A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancer. , 2002, Genes & development.

[23]  J. D. den Dunnen,et al.  Protein truncation test (PTT) for rapid detection of translation-terminating mutations. , 1993, Human molecular genetics.

[24]  B. Sykes,et al.  Mutations within the gene encoding the alpha 1 (X) chain of type X collagen (COL10A1) cause metaphyseal chondrodysplasia type Schmid but not several other forms of metaphyseal chondrodysplasia. , 1996, Journal of medical genetics.

[25]  J. Lykke-Andersen,et al.  mRNA quality control: Marking the message for life or death , 2001, Current Biology.

[26]  W. Cole,et al.  Type X Collagen Multimer Assembly in Vitro Is Prevented by a Gly618 to Val Mutation in the α1(X) NC1 Domain Resulting in Schmid Metaphyseal Chondrodysplasia (*) , 1995, The Journal of Biological Chemistry.

[27]  H. Dietz,et al.  Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.

[28]  L. Maquat NASty effects on fibrillin pre-mRNA splicing: another case of ESE does it, but proposals for translation-dependent splice site choice live on. , 2002, Genes & development.

[29]  J. Steitz,et al.  Communication of the Position of Exon-Exon Junctions to the mRNA Surveillance Machinery by the Protein RNPS1 , 2001, Science.

[30]  J. Bateman,et al.  A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. , 2001, The American journal of pathology.

[31]  J. Mendell,et al.  Separable Roles for rent1/hUpf1 in Altered Splicing and Decay of Nonsense Transcripts , 2002, Science.

[32]  A. Shyu,et al.  RNA surveillance by nuclear scanning? , 2002, Nature Cell Biology.

[33]  A. Poole,et al.  Immunoelectron microscopic studies of type X collagen in endochondral ossification , 1989, The Journal of cell biology.

[34]  J. Yates,et al.  Transforming functions associated with Epstein-Barr virus. , 1984, The Journal of investigative dermatology.

[35]  Jun Wang,et al.  A Quality Control Pathway That Down-regulates Aberrant T-cell Receptor (TCR) Transcripts by a Mechanism Requiring UPF2 and Translation* , 2002, The Journal of Biological Chemistry.

[36]  D. Sillence,et al.  A nonsense mutation in the carboxyl-terminal domain of type X collagen causes haploinsufficiency in schmid metaphyseal chondrodysplasia. , 1998, The Journal of clinical investigation.